Skip to main content

Humeral Fractures

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Cast removal at home using a telemedicine toolN/A1 trial
Active Trials
NCT02640027Completed50Est. Jun 2017
NuVasive
NuVasiveCA - San Diego
1 program
Humeral Compression/DistractionN/A1 trial
Active Trials
NCT02861495Terminated2Est. Aug 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NuVasiveHumeral Compression/Distraction
Angeles TherapeuticsCast removal at home using a telemedicine tool

Clinical Trials (2)

Total enrollment: 52 patients across 2 trials

NCT02861495NuVasiveHumeral Compression/Distraction

Humeral Compression/Distraction Device

Start: Sep 2016Est. completion: Aug 20182 patients
N/ATerminated
NCT02640027Angeles TherapeuticsCast removal at home using a telemedicine tool

The Use of Telemedicine Tool in Supracondylar Humerus Fractures in Children

Start: Mar 2016Est. completion: Jun 201750 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.